Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Diabetes Mellitus: Introduction

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...

Pathophysiology of Diabetes

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...

Diabetes: Symptoms, Diagnosis, and Complications

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...

Hyperglycemia

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The development of chronic hypertension in a subsequent pregnancy after pre-eclampsia with severe features based on gestational age.

American journal of obstetrics & gynecology MFM·2026

Same author

Evaluating the Impact of Gestational Weight Gain Based on an Increase in BMI Class in Patients with Obesity During Pregnancy.

Maternal and child health journal·2025

Same author

Intrapartum Glycemic Control with Insulin Infusion versus Rotating Fluids: A Randomized Controlled Trial.

American journal of perinatology·2025

Same author

A retrospective review of the association between maternal body mass index and the risk of congenital anomalies.

Congenital anomalies·2023

Same author

Induction of labor with prostaglandins for pregnancies with small for gestational age neonates.

American journal of obstetrics & gynecology MFM·2023

Same author

Preeclampsia and Long-term Kidney Outcomes: An Observational Cohort Study.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2023

Search research articles

Related Experiment Video

Updated: Jun 5, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Gestational diabetes: evolving diagnostic criteria.

Michael J Paglia¹, Donald R Coustan

¹Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Warren Alpert Medical School of Brown University, Women & Infants Hospital of Rhode Island, Providence, Rhode Island, USA.

Current Opinion in Obstetrics & Gynecology

|December 24, 2010

Summary

Gestational diabetes mellitus (GDM) diagnosis is debated. Recent studies, including the HAPO study, show a continuous link between maternal glucose levels and pregnancy outcomes, supporting GDM treatment benefits.

More Related Videos

Electrochemiluminescence Assays for Human Islet Autoantibodies

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test

Published on: November 13, 2016

Related Experiment Videos

Last Updated: Jun 5, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Electrochemiluminescence Assays for Human Islet Autoantibodies

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test

Published on: November 13, 2016

Area of Science:

Obstetrics and Gynecology
Endocrinology
Perinatal Medicine

Background:

Gestational diabetes mellitus (GDM) is a frequent pregnancy complication with ongoing debate regarding optimal diagnostic criteria and treatment efficacy.
Current international guidelines for GDM screening and diagnosis lack universal consensus.
Understanding the relationship between maternal hyperglycemia and adverse pregnancy outcomes is crucial for clinical practice.

Purpose of the Study:

To review current controversies in gestational diabetes mellitus (GDM) screening and diagnosis.
To evaluate the benefits of GDM treatment on maternal and neonatal outcomes.
To discuss the impact of recent research, including the HAPO study, on GDM management.

Main Methods:

Review of three major studies published within the last two years.
Analysis of the Hyperglycemia and Adverse Pregnancy Outcomes (HAPO) study data.
Evaluation of studies assessing the impact of treating mild GDM.

Main Results:

The HAPO study revealed a continuous relationship between maternal glycemia and adverse pregnancy outcomes, rather than a definitive diagnostic threshold.
Two independent studies demonstrated significant benefits in both maternal and neonatal outcomes following the diagnosis and treatment of mild GDM.
Recent recommendations for GDM screening criteria have been proposed based on HAPO study findings.

Conclusions:

The HAPO study results offer a potential resolution to international confusion regarding GDM diagnosis.
New screening criteria for GDM have been recommended by the International Association of Diabetes and Pregnancy Study Groups.
Global professional organizations are actively considering these new recommendations for GDM management.